Skip to main content
    D

    DocGo Inc (DCGO)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $0.27
    -0.03 (-10.98%)

    Market Cap: $30.20M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    45%(9/20)
    Avg Surprise
    +16514.14%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.13
    Range$-0.15 - $-0.11
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.02-684.8%
    60d ago$-0.02-684.8%
    30d ago$-0.02-684.8%
    7d ago$-0.02-684.8%
    Current$-0.13
    Revenue Consensus
    $77M
    Range$76M - $79M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.46
    Range$-0.58 - $-0.33
    2 analysts
    Revenue Consensus
    $81M
    Range$80M - $82M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.46---
    Sep 26EST
    		-$-0.13---
    Jun 26
    Reported Aug 17
    		$0.16$-0.04+500.00%Beat+245.5%
    Mar 26
    Reported May 11
    		$-0.33$-0.06-450.00%Miss-94.1%
    Dec 25
    Reported Mar 16
    		$-1.68$-0.14-1065.56%Miss-3511.4%
    Sep 25
    Reported Nov 10
    		$-0.25$-0.40+37.50%Beat-200.0%
    Jun 25
    Reported Aug 7
    		$-0.11$-0.06-83.33%Miss-137.9%
    Mar 25
    Reported May 8
    		$-0.17$0.03-666.67%Miss-136.2%
    Dec 24
    Reported Feb 27
    		$0.05N/A-76.60%Miss-29.7%
    Sep 24
    Reported Nov 7
    		$0.25$0.24+4.17%Beat+8.7%
    Jun 24
    Reported Aug 7
    		$0.29$0.35-17.14%Miss+383.3%
    Mar 24
    Reported May 8
    		$0.47$0.34+38.24%Beat+487.5%
    Dec 23
    Reported Feb 28
    		$0.07$0.10-30.00%Miss+600.0%
    Sep 23
    Reported Nov 6
    		$0.23$0.21+9.52%Beat+91.7%
    Jun 23
    Reported Aug 7
    		$0.06N/A-57.14%Miss-87.8%
    Mar 23
    Reported May 8
    		$0.08$0.09-11.11%Miss-78.9%
    Dec 22
    Reported Mar 13
    		$0.01N/A-80.00%Miss-95.7%
    Sep 22
    Reported Nov 7
    		$0.12$0.17-29.41%Miss-99.9%
    Jun 22
    Reported Aug 8
    		$0.49$0.13+276.92%Beat+1325.0%
    Mar 22
    Reported May 9
    		$0.38$0.19+100.00%Beat+171.4%
    Dec 21
    Reported Mar 14
    		$0.23$0.02+1050.00%Beat+2400.0%
    Sep 21
    Reported Nov 15
    		$99.28$0.03+330833.33%Beat-
    Jun 21
    Reported Aug 11
    		$-0.04N/AN/ABeat-
    Mar 21
    Reported Jun 3
    		$0.14N/AN/ABeat-
    Dec 20
    Reported Mar 30
    		$-0.01N/AN/ABeat-
    Sep 20
    Reported Nov 25
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.13EV/EBITDAN/A
    Price/FCF-1.04xFCF Yield-96.26%
    Profitability
    Profit Margin-65.30%Operating Margin-24.40%
    ROE-107.80%ROIC-148.12%
    Financial Health
    Debt/Equity0.07xInterest CoverageN/A
    Current Ratio1.66xQuick Ratio1.66x
    Trading Statistics
    Beta0.97Avg Volume617.26K
    52-Week High$1.6552-Week Low$0.27

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.34
    SMA 20$0.35
    SMA 50$0.42
    SMA 200$0.61
    EMA 10$0.33
    EMA 20$0.35
    EMA 50$0.41
    EMA 200$0.66

    MACD

    Line: -0.03Signal: -0.03Hist: -0.00

    ADX

    ADX: 28.9+DI: 12.1-DI: 34.9

    Aroon & PSAR

    Aroon Up60.0
    Aroon Down100.0
    PSAR$0.40

    Bollinger Bands

    Upper Band$0.41
    Lower Band$0.30
    %B Position3227%(Upper)
    Band Width-0.21

    RSI (14-Day)

    Oversold
    25.1

    Momentum Oscillators

    Stoch %K8.3
    Stoch %D15.9
    Williams %R-99.7
    ROC (10d)-32.1%
    Momentum-0.13
    CCI (20d)-230.2
    MFI (14d)41.3

    Volatility Measures

    ATR (14d)$0.03(11.6%)
    StdDev (20d)0.03
    Hist Vol71.5%(High)

    Volume Flow

    VWAP$0.29
    OBV12.8M
    AD Line-50.9M
    CMF (20d)-0.338

    Volume Metrics

    Avg Vol (20d)643.0K
    Vol Ratio1.9x(High)
    VWMA (20d)$0.35

    Pivot Points

    R3$0.37
    R2$0.35
    R1$0.33
    Pivot Point$0.31
    S1$0.29
    S2$0.28
    S3$0.25

    Advanced Oscillators

    TSI-28.86
    Ultimate Osc25.6
    KST-145.17

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$73.42M$75.55M$74.94M$70.81M$80.42M$96.03M$120.83M$138.68M$164.95M$192.09M$199.25M$186.55M
    Cost of Revenue$0$0$223.44M$0$0$0$402.98M$0$0$0$297.40M$131.50M
    Gross Profit$73.42M$75.55M$-148,502,613$70.81M$80.42M$96.03M$-282,147,484$138.68M$164.95M$192.09M$-98,157,910$55.05M
    Operating Expenses$91.35M$94.26M$-43,923,104$112.79M$97.90M$110.03M$-274,674,297$128.55M$154.80M$176.21M$-109,831,568$46.34M
    R&D$3.45M$3.71M$3.77M$3.19M$2.96M$3.64M$3.69M$3.15M$2.37M$2.39M$3.19M$3.24M
    SG&A$29.74M$30.84M$39.21M$30.09M$31.24M$32.90M$35.04M$28.78M$34.75M$40.18M$43.51M$33.62M
    Operating Income$-17,922,223$-18,711,091$-104,579,509$-41,976,309$-17,480,244$-13,997,438$-7,473,187$10.14M$10.15M$15.88M$11.67M$8.71M
    Interest Income$-97,583$-99,732$-598,567$-246,896$-482,479$-466,982$-627,585$-587,827$-577,664$-452,175$774,177$250,873
    Interest Expense$13,946$0$7.03M$1.19M$436,394$805,549$0$1.10M$581,655$152,984$0$0
    Income Before Tax$-17,936,169$-16,680,554$-111,610,573$-43,168,791$-17,916,638$-14,802,987$-6,575,256$9.03M$9.57M$15.72M$12.20M$9.16M
    Income Tax Expense$56,129$19,283$30.73M$-13,511,429$-4,626,745$-3,723,687$1.07M$4.49M$3.71M$5.12M$4.20M$4.53M
    Net Income$-17,992,298$-16,699,837$-142,340,600$-29,657,362$-13,289,893$-11,079,300$-7,646,926$4.55M$5.86M$10.60M$7.99M$4.63M
    EBITDA$-15,233,553$-14,011,719$-107,158,725$-39,020,149$-13,598,554$-10,574,614$-2,624,746$13.80M$14.35M$20.36M$16.85M$13.24M
    EBIT$-17,838,586$-16,580,822$-111,012,006$-42,921,895$-17,434,159$-14,336,005$-5,947,671$9.62M$10.15M$16.17M$12.23M$8.91M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DCGO

    News

    New loan financing brings a warrant for up to 4M DocGo (DCGO) shares.

    DocGo (DCGO) has amended and restated its credit agreement, securing an additional $12.5 million funded loan (Term Loan B) and another $12.5 million (Term Loan C) tied to a merger. As part of this financing...

    Stock Titan•10/5/26•Somewhat-Bearish

    BTIG Maintains DocGo(DCGO.US) With Hold Rating

    BTIG has reiterated its Hold rating for DocGo (DCGO.US). This indicates that the analyst firm is not recommending buying or selling the stock at this time...

    Moomoo•10/2/26•Neutral

    Promising Penny Stocks To Consider In October 2026

    This article highlights three promising penny stocks for October 2026: DocGo (DCGO), Motorsport Games (MSGM), and Blue Ridge Bankshares (BRBS). Each company is analyzed for its financial health, recent performance...

    Simply Wall Street•10/1/26•Somewhat-Bearish

    DocGo Price Target Maintained With a $3.00/Share by Needham

    Needham has reiterated its Buy rating for DocGo (NASDAQ:DCGO) and maintained a price target of $3.00 per share. This suggests that Needham continues to see significant upside potential for the company's stock.

    Moomoo•9/30/26•Somewhat-Bullish

    Needham reiterates Buy rating on DocGo, $3 price target

    Needham has reiterated its Buy rating on DocGo (DCGO) with a $3.00 price target, suggesting a significant upside of 715.2% from its previous closing price. The positive outlook is attributed to DocGo's strategic...

    TradingView•9/30/26•Bullish

    DCGO Valuation and Fair Value

    P/E
    -0.1x
    Forward P/E
    60.2x
    P/FCF
    -1.0x
    P/B
    0.2x
    See GNG's fair value

    DCGO Profitability: Margins, ROIC and FCF

    Gross margin
    24.2%
    Operating margin
    -24.4%
    Net margin
    -65.3%
    ROIC
    -148.1%
    ROE
    -107.8%
    FCF margin
    -8.8%
    FCF yield
    -96.3%

    DCGO Competitors

    CompanyTicker
    Barinthus Biotherapeutics plcBRNS
    NextCure IncNXTC
    Actinium Pharmaceuticals IncATNM
    Nortech Systems IncorporatedNSYS
    Milestone ScientificMLSS
    Picard Medical, Inc.PMI
    CEL-SCI CorpCVM
    Sangamo Therapeutics IncSGMO

    Sector: Healthcare

    DCGO Analyst Ratings

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    1
    Buy
    1
    Hold
    3
    Sell
    0
    Strong Sell
    0

    DCGO Bull Case vs Bear Case

    Bear case

    • DCGO has a -65.3% net profit margin.
    • DCGO beat EPS estimates in 37.5% of its last 8 reported quarters.
    • DCGO's quarterly revenue changed -8.7% year over year.

    DCGO Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -225.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.13
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About DCGO

    Does DCGO pay dividends?

    DocGo Inc (DCGO) does not currently pay a regular dividend.

    What is DCGO's market cap?

    DocGo Inc (DCGO) has a market capitalization of $30.20M with a current stock price of $0.27.

    Related stocks

    Sector: Healthcare

    All stocks starting with D

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In